UBS cuts Adient price target to $23
UBS reduced its Adient price target to $23.00 from $29.00, according to ratings actions cited by Benzinga.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results.
Adient maintained at Buy; UBS cuts price target to $23
UBS maintained its Buy rating on Adient and cut its price target to $23.00 from $29.00.